India's CDSCO has warned pharma firms against promoting prescription weight-loss drugs (GLP-1s) via surrogate or digital ads, ...
The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for presc ...
As blockbuster weight-loss drugs surge in India, regulators warn that "awareness campaigns" may be blurring the line between public health messaging and pharmaceutical marketing.
The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for prescription-only drugs. The regulator in an advisory ...
India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns that could act as surrogate ...
Abstract: Coordinated Cyber-Physical Attacks (CCPAs) are increasingly significant due to their potential for widespread disruption. In this regard, choosing appropriate types of physical and ...
A 10 per cent increase in global oil prices is estimated to have a direct impact of approximately 0.7-1 per cent on India's Wholesale Price Index (WPI). According to a report by Bank of Baroda on the ...